Skip to content
★ Sign in to follow
비엘

비엘팜텍 Stock: price and insider trades · South Korea

KR·Mcap ₩59.4BHealth Care

No insider purchase over the last 90 days. The latest, by 상상콘텐츠투자조합, was filed 17 Mar 2026.

비엘팜텍: what insiders have been doing

비엘팜텍 is a Health Care company. Its directors and officers file their transactions with DART (FSS). In the past year (2 November 2025 to 2 November 2026), 4 filings came from 2 insiders.

Purchases and sales both appear in the filings: 3 purchases (2 insiders) and 1 sale (1 insider). The totals exclude 4 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 1 chief executive.

The most recent open-market purchase was published on 17 March 2026, 238 days ago.

For context, the typical company on the same exchange (median of 2,655 companies) published 7 filings over the same period, against 4 filings here. Our records for 비엘팜텍 go back to 2021, with 3 purchases and 31 sales on the open market in total.

For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and UCB. Source: insider filings from DART (FSS). Past trades are no guide to future returns.

Insider Decl.
46
Thresholds
n/a
Buy Volume
€7M
3 ops. · all time
Sell Volume
€741M
31 ops. · all time

Who traded when

BuySale
박영철2 buys2 sales
상상콘텐츠투자조합1 buy1 sale
송상근1 sale
신동진1 sale

Since the insiders bought

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Fundamental score
Ranked 21,259 of 26,911 companies
31.5
score / 100
Value
23
Quality
40
FCF yld-0.5%
Earn yld-28%
EV/EBITDA·
ROE-104%
Gross mgn57%
Net mgn·
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

₩2,130
Analyst consensus
·
Income statement
Revenue₩6.5B
Gross profit₩3.7B57% margin
EBITDA-₩15.3B-236% margin
Net income-₩16.8B-257.9% margin
Valuation
Beta2.46
Balance sheet & cash
Market cap₩59.4B
Total debt₩5B
Free Cash Flow-₩290.9M
Debt / Equity41%
Profitability & ownership
ROE-103.8%
ROA-2.9%
% insiders26.7%
% institutions0.0%
Last declaration on 23 March 2026
Declarations46 total
  • ▼
    Related company / holdingExecutives
    €845kest.0DART
    615,384 sharesKRXDART:20260323000063
  • ▲
    Related company / holdingExecutives
    €6.8Mest.0DART
    2,457,183 sharesKRXDART:20260317000603
    Canonical exit: 28 Oct 2025 (T+90)
  • ▲
    대표이사Executives(filed)
    €66kest.0DART
    29,000 sharesShareKRXDART:20260121000487
    Canonical exit: 21 Apr 2026 (T+90)
  • ▲
    대표이사Executives(filed)
    €37kest.0DART
    130,774 sharesShareKRXDART:20260114000281
    Canonical exit: 14 Apr 2026 (T+90)
  • ▼
    Executives
    0DART
    21,424,541 sharesKRXDART:20241216000288
  • ▼
    대표이사Executives(filed)
    0DART
    19,646,003 sharesShareKRXDART:20241216000248
  • ▼
    사내이사Executives(filed)
    €507kest.0DART
    979,801 sharesShareKRXDART:20241216000229
  • ▼
    감사Executives(filed)
    €93kest.0DART
    180,183 sharesShareKRXDART:20241216000243
  • ▼
    Executives
    €21.0Mest.0DART
    21,424,541 sharesKRXDART:20231219000354
  • ●
    사내이사Executives
    0DART
    ShareKRXDART:20231219000346
  • ▼
    Executives
    0DART
    21,424,541 sharesKRXDART:20231208000584
  • ▼
    Executives
    0DART
    21,424,541 sharesKRXDART:20230714000524
  • ▼
    Executives
    0DART
    21,424,541 sharesKRXDART:20230614000379
  • ▼
    Executives
    0DART
    21,424,541 sharesKRXDART:20230512001193
  • ▼
    Executives
    €29.1Mest.0DART
    21,424,541 sharesKRXDART:20230428001253
  • ▼
    Executives(filed)
    0DART
    21,424,541 sharesKRXDART:20230414002452
  • ●
    Executives
    Executives(filed)
    0DART
  • ▼
    Executives(filed)
    0DART
    21,424,541 sharesKRXDART:20221216000508
  • ▼
    Executives(filed)
    €39.3Mest.0DART
    21,424,541 sharesKRXDART:20221028000547
  • ▼
    Executives(filed)
    0DART
    21,424,541 sharesKRXDART:20221014000497
  • ●
    사내이사Executives(filed)
    0DART
    ShareKRXDART:20220907000233
  • ●
    사내이사Executives(filed)
    0DART
    ShareKRXDART:20220829000294
  • ●
    사내이사Executives(filed)
    0DART
    ShareKRXDART:20220822000241
  • ▼
    Executives(filed)
    €48.3Mest.0DART
    21,424,541 sharesKRXDART:20220729000542
  • ▼
    Executives(filed)
    0DART
    21,424,541 sharesKRXDART:20220715000501

25 of 46 declarations

About 비엘팜텍

비엘팜텍 is a company listed on the XKRX market, specializing in the health and pharmaceutical sector. It focuses on the development and commercialization of innovative pharmaceutical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations